Physician profile
Bina Jain
NPI 1437363009
$806.82
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.75 · 2020: $288 · 2021: $452.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.07 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $74.07 | 2021 | |
| Novo Nordisk INC | $72.19 | 2020-2021 | |
| Glaxosmithkline, LLC. | $66.57 | 2019-2021 | |
| Astellas Pharma US INC | $63.06 | 2019-2021 | |
| Lilly USA, LLC | $62.71 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.82 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $50.45 | 2020-2021 | |
| Pfizer INC. | $37.96 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $35.66 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $27.58 | 2020-2021 | |
| Abbott Laboratories | $24.96 | 2019 | |
| Ibsa Pharma INC. | $24.85 | 2020 | |
| Sunovion Pharmaceuticals INC. | $15.95 | 2021 | |
| Amgen INC. | $14.79 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.48 | 2020 | |
| Amarin Pharma, INC. | $14.12 | 2020 | |
| Philips North America LLC | $13.65 | 2020 | |
| Daiichi Sankyo INC. | $12.06 | 2021 | |
| Biodelivery Sciences International, INC. | $11.91 | 2020 | |
| Mannkind Corporation | $11.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bina Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.